Cargando…

Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice

BACKGROUND & PURPOSE: Non-alcoholic fatty liver disease (NAFLD) is characterised by the excessive accumulation of triglycerides in the liver. Shenling Baizhu powder (SLBZP) is formulated from various natural medicinal plants that protect the liver and are used to treat intestinal diseases. SLBZP...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Zheng, Guo, Jia, Du, Bing, Hong, Li, Zhu, Ying, Feng, Xiaoyi, Hou, Yuanlu, Shi, Anhua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394096/ https://www.ncbi.nlm.nih.gov/pubmed/37538846 http://dx.doi.org/10.3389/fmicb.2023.1147067

Ejemplares similares

Lipidomic Analysis of the Protective Effects of Shenling Baizhu San on Non-Alcoholic Fatty Liver Disease in Rats
por: Deng, Yuanjun, et al.
Publicado: (2019)

Prevention of Nonalcoholic Hepatic Steatosis by Shenling Baizhu Powder: Involvement of Adiponectin-Induced Inhibition of Hepatic SREBP-1c
por: Tang, Kairui, et al.
Publicado: (2020)

Prevention of polycystic ovary syndrome and postmenopausal osteoporosis by inhibiting apoptosis with Shenling Baizhu powder compound
por: Liang, Jing, et al.
Publicado: (2022)

Effect of Shenling Baizhu powder on immunity to diarrheal disease: A systematic review and meta-analysis
por: Chen, Qian, et al.
Publicado: (2022)

Effects of Shenling Baizhu powder on pyrotinib-induced diarrhea: analysis of gut microbiota, metabonomics, and network pharmacology
por: Lai, Jingjiang, et al.
Publicado: (2022)

A Network Pharmacology-Based Study on Irritable Bowel Syndrome Prevention and Treatment Utilizing Shenling Baizhu Powder
por: Meng, Meng, et al.
Publicado: (2021)

Quantitative proteomics analysis based on data-independent acquisition reveals the effect of Shenling Baizhu powder (SLP) on protein expression in MAFLD rat liver tissue
por: Song, Sufei, et al.
Publicado: (2023)

Traditional Chinese medicine prescription Shenling BaiZhu powder to treat ulcerative colitis: Clinical evidence and potential mechanisms
por: Chen, Jing, et al.
Publicado: (2022)

Effect of Shenling Baizhu San on Intestinal Flora in a Rat Model of Ulcerative Colitis with Spleen Deficiency and Dampness
por: Luo, Yiting, et al.
Publicado: (2022)

Herbal Formula Shenling Baizhu San for Chronic Diarrhea in Adults: A Systematic Review and Meta-analysis
por: Wang, Hui, et al.
Publicado: (2022)

Effects of Lactobacillus plantarum fermented Shenling Baizhu San on gut microbiota, antioxidant capacity, and intestinal barrier function of yellow-plumed broilers
por: Lv, Weijie, et al.
Publicado: (2023)

Effects of ShenLing BaiZhu San Supplementation on Gut Microbiota and Oxidative Stress in Rats with Ulcerative Colitis
por: Gu, Daxing, et al.
Publicado: (2021)

Shenling Baizhu Powder Alleviates TNBS-Induced Colitis in Rats by Improving Intestinal Epithelial Permeability and Inhibiting Inflammation Through the TLR5/MyD88/NF-κB Pathway
por: Rao, Kehan, et al.
Publicado: (2022)

Shenling Baizhu Powder Inhibits RV-SA11-Induced Inflammation and Rotavirus Enteritis via TLR4/MyD88/NF-κB Signaling Pathway
por: Wang, Xiaoyan, et al.
Publicado: (2021)

A randomized controlled trial for the effect of Modified Shenling Baizhu Powder on delaying the illness progress of COPD stable phase patients (GOLD 1–2 stages): A study protocol
por: Liu, Yufei, et al.
Publicado: (2020)

Shenling Baizhu San supresses colitis associated colorectal cancer through inhibition of epithelial-mesenchymal transition and myeloid-derived suppressor infiltration
por: Lin, Xiaochang, et al.
Publicado: (2015)

Chinese Herbal Medicine Formula Shenling Baizhu San Ameliorates High-Fat Diet-Induced NAFLD in Rats by Modulating Hepatic MicroRNA Expression Profiles
por: Pan, Maoxing, et al.
Publicado: (2019)

Evaluation of the teratogenic effects of three traditional Chinese medicines, Si Jun Zi Tang, Liu Jun Zi Tang and Shenling Baizhu San, during zebrafish pronephros development
por: Ding, Yu-Ju, et al.
Publicado: (2015)

Antinociceptive Effects of Shenling Baizhu through PI3K-Akt-mTOR Signaling Pathway in a Mouse Model of Bone Metastasis with Small-Cell Lung Cancer
por: Feng, Zhe, et al.
Publicado: (2020)

Small intestinal bacterial overgrowth and nonalcoholic fatty liver disease
por: Augustyn, Monika, et al.
Publicado: (2019)

Intestinal Barrier Function in the Pathogenesis of Nonalcoholic Fatty Liver Disease
por: Liu, Lu, et al.
Publicado: (2023)

Food and Gut Microbiota-Derived Metabolites in Nonalcoholic Fatty Liver Disease
por: Jeong, Min Kyo, et al.
Publicado: (2022)

The Mitochondrial Trigger in an Animal Model of Nonalcoholic Fatty Liver Disease
por: Chimienti, Guglielmina, et al.
Publicado: (2021)

Insulin dysregulation drives mitochondrial cholesterol metabolite accumulation: initiating hepatic toxicity in nonalcoholic fatty liver disease
por: Minowa, Kei, et al.
Publicado: (2023)

Simultaneous Determination of Ten Bioactive Components from Shenling Baizhu San in Rat Plasma by UHPLC-MS/MS: Application to a Comparative Pharmacokinetic Study in Normal and Two Models of Ulcerative Colitis Rats
por: Xu, Xia, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

Amelioration of Intestinal Barrier Dysfunction by Berberine in the Treatment of Nonalcoholic Fatty Liver Disease in Rats
por: Li, Donghao, et al.
Publicado: (2017)

Gene-metabolite network analysis in different nonalcoholic fatty liver disease phenotypes
por: Liu, Xiao-Lin, et al.
Publicado: (2017)

The Microbiota and It’s Correlation With Metabolites in the Gut of Mice With Nonalcoholic Fatty Liver Disease
por: Gu, Congwei, et al.
Publicado: (2022)

Interplay of Lymphocytes with the Intestinal Microbiota in Children with Nonalcoholic Fatty Liver Disease
por: Liang, Tian, et al.
Publicado: (2022)

Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis
por: Zhang, Yang, et al.
Publicado: (2021)

Role of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease
por: Li, Ruibing, et al.
Publicado: (2020)

Mitochondrial Dysfunction Plays Central Role in Nonalcoholic Fatty Liver Disease
por: Ramanathan, Raghu, et al.
Publicado: (2022)

Herbal therapy for ameliorating nonalcoholic fatty liver disease via rebuilding the intestinal microecology
por: Yang, Xiao-Fang, et al.
Publicado: (2021)

Effects of garlic polysaccharide on alcoholic liver fibrosis and intestinal microflora in mice
por: Wang, Yuchuan, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease stratification by liver lipidomics
por: Vvedenskaya, Olga, et al.
Publicado: (2021)

Nonalcoholic Fatty Liver Disease after Liver Transplant
por: Shetty, Akshay, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease and non-liver comorbidities
por: Manikat, Richie, et al.
Publicado: (2023)

Efficacy and safety of Shenling Atractylodes Powder in the treatment of ulcerative colitis: A protocol for systematic review and meta-analysis
por: Zhang, Quanhui, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_thhlle8enjniq44h0i7243raui